US 12,290,548 B2
Herbal composition for reducing uric acid and the use in reducing uric acid, body fat, and blood glucose thereof
William Tien-hung Chang, New Taipei (TW); and Wei-ting Chang, New Taipei (TW)
Assigned to LYTONE ENTERPRISE, INC., New Taipei (TW)
Filed by LYTONE ENTERPRISE, INC., New Taipei (TW)
Filed on Jun. 16, 2021, as Appl. No. 17/349,061.
Claims priority of application No. 109120486 (TW), filed on Jun. 17, 2020.
Prior Publication US 2021/0393730 A1, Dec. 23, 2021
Int. Cl. A61K 36/79 (2006.01); A61K 36/064 (2006.01); A61K 36/42 (2006.01); A61K 36/605 (2006.01); A61K 36/61 (2006.01); A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61K 36/8998 (2006.01); A61P 3/04 (2006.01)
CPC A61K 36/8998 (2013.01) [A61K 36/064 (2013.01); A61K 36/42 (2013.01); A61K 36/605 (2013.01); A61K 36/61 (2013.01); A61K 36/79 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61P 3/04 (2018.01)] 5 Claims
OG exemplary drawing
 
1. A method of treating hyperuricemia or gout, comprising
administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising:
1-2 parts by weight of an extract of Schisandra chinensis and
5-10 parts by weight of an extract of Psidium guajava,
wherein the therapeutically effective amount is an amount effective to inhibit xanthine oxidase activity in the subject.